In 2015 the NHMRC accredited Sydney Health Partners (SHP) as an Advanced Health Research Translation Centre, and recognised as a world leader in translating research into better health outcomes for our community. Patient and public benefit is at the core of what we do. Through our Partnership we are committed to conducting and using health and medical research to improve the lives of our patients and community faster and more consistently.
The Medical Research Future Fund (MRFF) provides a long term sustainable source of funding for endeavours that aim to improve health outcomes, quality of life and health system sustainability across Australia. It made an initial funding allocation to SHP of $2.2M for 2018 under the Rapid Applied Research Translation Program, and a further commitment of $6.1M for the period 2019-2021.
SHP will release up to $2M of MRFF money through the current Round 3, for 12-month grants commencing January 2019.
Round 3 applications have now closed, and are currently being reviewed. Final funding decisions will be announced by the end of September 2018.
A further funding round (Round 4) is expected in the second half of 2019 for grants commencing January 2020.